1. Home
  2. GTBP vs WNW Comparison

GTBP vs WNW Comparison

Compare GTBP & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • WNW
  • Stock Information
  • Founded
  • GTBP 1965
  • WNW 2015
  • Country
  • GTBP United States
  • WNW China
  • Employees
  • GTBP N/A
  • WNW N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • WNW Catalog/Specialty Distribution
  • Sector
  • GTBP Health Care
  • WNW Consumer Discretionary
  • Exchange
  • GTBP Nasdaq
  • WNW Nasdaq
  • Market Cap
  • GTBP 5.5M
  • WNW 5.7M
  • IPO Year
  • GTBP N/A
  • WNW 2020
  • Fundamental
  • Price
  • GTBP $1.77
  • WNW $1.78
  • Analyst Decision
  • GTBP Strong Buy
  • WNW
  • Analyst Count
  • GTBP 1
  • WNW 0
  • Target Price
  • GTBP $11.00
  • WNW N/A
  • AVG Volume (30 Days)
  • GTBP 74.2K
  • WNW 31.7K
  • Earning Date
  • GTBP 08-13-2025
  • WNW 08-12-2025
  • Dividend Yield
  • GTBP N/A
  • WNW N/A
  • EPS Growth
  • GTBP N/A
  • WNW N/A
  • EPS
  • GTBP N/A
  • WNW 9.06
  • Revenue
  • GTBP N/A
  • WNW $158,485.00
  • Revenue This Year
  • GTBP N/A
  • WNW N/A
  • Revenue Next Year
  • GTBP N/A
  • WNW N/A
  • P/E Ratio
  • GTBP N/A
  • WNW $0.20
  • Revenue Growth
  • GTBP N/A
  • WNW N/A
  • 52 Week Low
  • GTBP $1.72
  • WNW $0.95
  • 52 Week High
  • GTBP $4.10
  • WNW $70.00
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 31.45
  • WNW 47.12
  • Support Level
  • GTBP $2.01
  • WNW $1.65
  • Resistance Level
  • GTBP $2.11
  • WNW $1.84
  • Average True Range (ATR)
  • GTBP 0.14
  • WNW 0.08
  • MACD
  • GTBP -0.01
  • WNW -0.01
  • Stochastic Oscillator
  • GTBP 8.77
  • WNW 46.71

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

Share on Social Networks: